PunjiPUNJI
Thematic FundMirae Asset Investment Managers (India) Pvt. Ltd

Mirae Asset Healthcare Fund - Direct Plan - Growth

Benchmark: BSE Healthcare TRI · Riskometer: Very High

Mirae Asset Healthcare Fund is a Thematic mutual fund managed by Mirae Asset Investment Managers (India) Pvt. Ltd, benchmarked against BSE Healthcare TRI. Riskometer: Very High.

View full analysis on Punji.ai →

₹50.875

NAV (2026-10-28)

₹3,497.63 Cr

AUM

0.62%

EXPENSE RATIO (DIRECT)

2018-06-11

INCEPTION

NAV History

LEARN: Growth of ₹100 · NAV · CAGR

CHART

Mirae Asset Healthcare Fund - growth of ₹100

Growth of ₹100 invested on 2026-09-30, not raw NAV - the standard way to compare fund performance regardless of NAV level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.

-102050801102026-09-302026-10-052026-10-082026-10-122026-10-152026-10-192026-10-222026-10-262026-10-28
NAV History - Last 30 Days(exact daily NAV)
DateNAV (₹)1D Change
2026-10-2850.875+0.485 (+1%)
2026-10-2750.39+1.227 (+2.5%)
2026-10-2649.163+0.875 (+1.8%)
2026-10-2548.288+0 (+0%)
2026-10-2348.288-0.534 (-1.1%)
2026-10-2248.822-0.082 (-0.2%)
2026-10-2148.904-0.285 (-0.6%)
2026-10-2049.189+0 (+0%)
2026-10-1949.189-0.539 (-1.1%)
2026-10-1849.728+0 (+0%)
2026-10-1649.728-0.106 (-0.2%)
2026-10-1549.834-0.072 (-0.1%)
2026-10-1449.906-0.526 (-1%)
2026-10-1350.432+0.026 (+0.1%)
2026-10-1250.406+0.004 (+0%)
2026-10-1150.402+0 (+0%)
2026-10-0950.402+0.506 (+1%)
2026-10-0849.896-1.148 (-2.2%)
2026-10-0751.044-0.108 (-0.2%)
2026-10-0651.152+0.568 (+1.1%)
2026-10-0550.584-0.56 (-1.1%)
2026-10-0451.144+0 (+0%)
2026-10-0151.144+0.088 (+0.2%)
2026-09-3051.056-
BQuality · 75.6/100
ASafety · 81.7/100
ACompound · 88.7/100

Punji Fund Health Score - percentile-within-category. See methodology.

CATEGORY COMPARISON

0.88

3Y Sharpe Ratio

#4 of 32 - median 0.30

1.0%

3Y Alpha

#16 of 32 - median 1.0%

14.5%

3Y Std Deviation

#7 of 32 - median 15.6%

0.62%

Total Expense Ratio

#2 of 62 - median 1.07%

₹3,498 Cr

AUM

#7 of 60 - median ₹972 Cr

73.34%

3Y Beat Benchmark %

vs BSE Healthcare TRI

Mirae Asset Healthcare Fund returns

Lumpsum returns: full range of outcomes across every overlapping window in the fund's history for each holding period, not one trailing number.

Holding periodMin rolling CAGRMedian rolling CAGRMax rolling CAGR
1Y-11.1%+19.2%+93.1%
3Y+14.2%+23%+35.7%

Actual point-to-point CAGR for the single best and single worst overlapping window of each holding period in the fund's history - historical fact, not a forecast. Independent of the lumpsum/SIP toggle above - always CAGR-based.

Holding periodBest windowWorst windowBeat benchmark
1Y+93.1% (2020-03-23 → 2021-03-23)-11.1% (2021-09-16 → 2022-09-16)65.88%
3Y+35.7% (2018-07-19 → 2021-07-18)+14.2% (2021-05-10 → 2024-05-09)73.34%

Mirae Asset Healthcare Fund category rank vs peers

MetricValueRankCategory median
3Y Rolling CAGR23.0%#5 of 31 17.6%
3Y Sharpe Ratio0.88#4 of 32 0.30
3Y Alpha1.0%#16 of 32 1.0%
3Y Std Deviation14.5%#7 of 32 (lower is better)15.6%
Total Expense Ratio0.62%#2 of 62 (lower is better)1.07%
AUM₹3,498 Cr#7 of 60 ₹972 Cr
3Y Max Drawdown15.90%#3 of 32 (lower is better)22.98%

Mirae Asset Healthcare Fund risk metrics

3-year window vs. BSE Healthcare TRI.

Mirae Asset Healthcare Fund holdings

Portfolio as of 2026-09-30

Hold multiple funds? See our Portfolio Overlap Tool to see if they actually hold different stocks.

CHART

Top sector holdings

Share of portfolio (% to NAV) in each of the top sectors.

75.7814%20.5159%TOP 5100%
Pharmaceuticals & Biotechnology 75.7814%Healthcare Services 20.5159%Chemicals & Petrochemicals 1.9039%Healthcare Equipment & Supplies 1.7711%Other 0.0276%

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd. (Pharmaceuticals & Biotechnology)10.1481%
Divi's Laboratories Ltd. (Pharmaceuticals & Biotechnology)9.7897%
Torrent Pharmaceuticals Ltd. (Pharmaceuticals & Biotechnology)6.8022%
Apollo Hospitals Enterprise Ltd. (Healthcare Services)5.6185%
Laurus Labs Ltd. (Pharmaceuticals & Biotechnology)5.5117%
Dr. Reddy's Laboratories Ltd. (Pharmaceuticals & Biotechnology)4.8396%
Glenmark Pharmaceuticals Ltd. (Pharmaceuticals & Biotechnology)4.7778%
Aurobindo Pharma Ltd. (Pharmaceuticals & Biotechnology)3.7769%
Alkem Laboratories Ltd. (Pharmaceuticals & Biotechnology)3.759%
IPCA Laboratories Ltd. (Pharmaceuticals & Biotechnology)3.3897%

Funds similar to Mirae Asset Healthcare Fund

Top funds in the same category, ranked by performance - not holdings overlap. Pick up to 2 to compare alongside this fund:

Mirae Asset Healthcare Fund Punji analytics

ADVANCED RISK-ADJUSTED METRICS

3-year window vs. BSE Healthcare TRI. Not commonly published by other Indian fund platforms.

CHART

Asset Allocation

As of Sep-2026

99.97%TOP 3100%
Equity 99.97%Debt 0%Cash 0.02%

CHART

Market Cap Split

As of Sep-2026

34.9917%42.1056%22.875%TOP 3100%
Large 34.9917%Mid 42.1056%Small 22.875%

Portfolio analytics as of Sep-2026.

Frequently asked questions

How often has Mirae Asset Healthcare Fund beaten its benchmark over 3-year periods?

Mirae Asset Healthcare Fund beat its benchmark, BSE Healthcare TRI, in 73.34% of all overlapping 3-year rolling windows in its history. This is different from simply having a positive return - it measures how often the fund's own 3-year CAGR exceeded the benchmark's 3-year CAGR over the exact same dates, which is a more direct read on the manager's stock selection than a single trailing alpha figure computed over one window.

What is Mirae Asset Healthcare Fund's 3-year rolling return, and how does it rank?

Mirae Asset Healthcare Fund's 3-year rolling CAGR (median across all rolling 3-year windows in the data) is 23.0%. That places it in the 87th percentile within its category, Thematic Fund - meaning it has outperformed roughly 87% of peers in the same category over this window. The category median for this metric is 17.6%, so comparing Mirae Asset Healthcare Fund's figure against that median shows how much it has beaten (or trailed) a typical fund in this category. Rolling returns average performance across many overlapping windows rather than a single start/end date, which makes them a steadier read on consistency than a simple point-to-point return.

How risky is Mirae Asset Healthcare Fund?

Mirae Asset Healthcare Fund carries a "Very High" risk rating on SEBI's mandated riskometer scale, the same standardized classification every Indian mutual fund must disclose. This rating reflects the fund's underlying portfolio composition and historical volatility, and is set independently of any single AMC's own marketing - it's meant to give investors a comparable, at-a-glance sense of how much the fund's value can swing before deciding whether it matches their own risk appetite and investment horizon. A higher-risk rating isn't inherently bad; it typically correlates with higher long-term return potential, but also with larger short-term drawdowns, so it should be read alongside the fund's category and your own time horizon rather than in isolation.

What is Mirae Asset Healthcare Fund's expense ratio?

Mirae Asset Healthcare Fund's direct-plan expense ratio is 0.62% per year - the annual fee the AMC deducts from the fund's assets to cover management and operating costs, already reflected in the NAV you see (it isn't billed separately). Direct plans skip the distributor commission built into Regular plans, which is why a direct-plan expense ratio is almost always lower than the same scheme's Regular-plan version. Over long holding periods, even a difference of a few basis points compounds into a meaningfully different final corpus, which is why expense ratio is one of the few fund attributes an investor can compare with total certainty before investing, unlike future returns.

How does Mirae Asset Healthcare Fund's expense ratio compare to its category?

Mirae Asset Healthcare Fund's expense ratio of 0.62% ranks #2 of 62 funds in the Thematic Fund category (lower is better) - the category median is 1.07%. Expense ratio is deducted from the fund's assets every year regardless of performance, so a lower ratio is a real, certain cost advantage rather than a projection, unlike future returns.

How big is Mirae Asset Healthcare Fund, and how does that compare to its category?

Mirae Asset Healthcare Fund manages ₹3,498 Cr in assets, ranking #7 of 60 funds by size in the Thematic Fund category - the category median is ₹972 Cr. A larger fund generally means deeper liquidity and lower per-unit fixed costs for the AMC to spread across investors, but in categories with a smaller investable universe (like small or mid cap), a very large fund can also face more difficulty entering and exiting positions without moving the price.

What's the worst drawdown Mirae Asset Healthcare Fund has experienced, and how does that compare to its category?

Mirae Asset Healthcare Fund's worst peak-to-trough decline over the last 3 years was 15.90%, ranking #3 of 32 funds in the Thematic Fund category (lower is better) - the category median is 22.98%. Max drawdown measures the deepest loss an investor holding through the worst stretch would have seen, before any recovery - a smaller number means a gentler ride, though it says nothing about how long the fund took to recover.

How has Mirae Asset Healthcare Fund performed against its benchmark, BSE Healthcare TRI?

Over a 3-year window, Mirae Asset Healthcare Fund has outperformed its benchmark, BSE Healthcare TRI, by 1.0% (alpha). Alpha measures the fund's return in excess of what its benchmark alone would have delivered, after adjusting for the risk taken (beta of 0.92 here) - a positive alpha means the fund manager's stock selection and allocation calls added real value beyond simply tracking the market, while a negative alpha means the fund would have been better replicated by a low-cost index fund tracking the same benchmark. This is a trailing, historical figure and isn't a guarantee of future outperformance.

What's the best and worst 3-year holding period for Mirae Asset Healthcare Fund historically?

Looking at every overlapping 3-year window in Mirae Asset Healthcare Fund's history, the best-performing window ran from 2018-07-19 to 2021-07-18, delivering a 35.7% CAGR. The worst-performing window ran from 2021-05-10 to 2024-05-09, delivering a 14.2% CAGR. This is a historical record of actual past outcomes, not a prediction - it shows the real range of results an investor holding for exactly 3 years could have seen depending on entry timing, which is why rolling returns (median across all windows, shown above) are a more representative single number than either extreme.

How concentrated are Mirae Asset Healthcare Fund's top holdings?

Mirae Asset Healthcare Fund's single largest disclosed holding, Sun Pharmaceutical Industries Ltd., accounts for 10.1481% of NAV. Its top 5 holdings together make up 37.9% of the portfolio, and its top 10 disclosed holdings make up 58.4% - as of 2026-09-30. A higher concentration in the top few names means the fund's returns lean more heavily on those specific bets paying off, while a flatter spread means no single holding drives outcomes as much either way.

Who manages Mirae Asset Healthcare Fund, and what category does it belong to?

Mirae Asset Healthcare Fund is managed by Mirae Asset Investment Managers (India) Pvt. Ltd and is classified under the Thematic Fund category, the SEBI-defined scheme categorization that groups funds by their investment mandate (market-cap focus, sector, or asset mix) so investors can compare like-for-like funds rather than across unrelated strategies. The AMC (asset management company) is the regulated entity legally responsible for the fund's operations, portfolio decisions, and disclosures, though day-to-day investment calls are made by a designated fund manager within the mandate set by the scheme's category and stated objective.

Data as of 2026-10-29. Source: AMFI disclosures via Punji. Not investment advice.